MBX Insider Trading

Insider Ownership Percentage: 14.07%
Insider Buying (Last 12 Months): C$5,996.35
Insider Selling (Last 12 Months): C$88,445.75

Microbix Biosystems Insider Trading History Chart

This chart shows the insider buying and selling history at Microbix Biosystems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Microbix Biosystems Share Price & Price History

Current Price: C$0.35
Price Change: Price Decrease of -0.01 (-2.78%)
As of 04/15/2024 01:00 AM ET

This chart shows the closing price history over time for MBX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Microbix Biosystems Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2024Bo HollasDirectorSell100,000C$0.39C$39,250.00
2/22/2024Steven Trevor HagermanSenior OfficerSell5,500C$0.40C$2,172.50
2/21/2024Cameron Lionel GroomeDirectorSell119,500C$0.39C$47,023.25
1/22/2024Jennifer Anne StewartDirectorBuy13,945C$0.43C$5,996.35
9/6/2022Peter Martin BlecherDirectorSell23,500C$0.52C$12,149.501,747,700
7/20/2022Cameron Lionel GroomeDirectorSell65,000C$0.52C$33,540.00625,000
5/17/2022Kenneth HughesSenior OfficerBuy11,500C$0.47C$5,347.50316,500
2/16/2022Cameron Lionel GroomeDirectorSell60,000C$0.61C$36,600.00315,000
12/30/2021James Stuart CurrieSenior OfficerSell14,500C$0.83C$12,035.00180,500
11/24/2021James Stuart CurrieSenior OfficerSell50,000C$0.68C$33,950.00275,000
11/16/2021Martin MarinoDirectorSell50,000C$0.73C$36,500.001,115,000
6/25/2021Martin MarinoDirectorBuy50,000C$0.54C$27,000.00251,667
6/23/2021Cameron Lionel GroomeDirectorBuy15,000C$0.55C$8,250.00215,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Microbix Biosystems (TSE:MBX)

0.42% of Microbix Biosystems stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Microbix Biosystems logo
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Read More on Microbix Biosystems

Today's Range

Now: C$0.35
Low: C$0.35
High: C$0.36

50 Day Range

MA: C$0.38
Low: C$0.35
High: C$0.43

52 Week Range

Now: C$0.35
Low: C$0.23
High: C$0.47

Volume

46,025 shs

Average Volume

74,267 shs

Market Capitalization

C$47.79 million

P/E Ratio

11.67

Dividend Yield

2.30%

Beta

0.28

Who are the company insiders with the largest holdings of Microbix Biosystems?

Microbix Biosystems' top insider shareholders include:
  1. Peter Martin Blecher (Director)
  2. Cameron Lionel Groome (Director)
  3. Kenneth Hughes (Senior Officer)
  4. Bo Hollas (Director)
  5. Jennifer Anne Stewart (Director)
  6. Steven Trevor Hagerman (Senior Officer)
Learn More about top insider investors at Microbix Biosystems.